Exelixis announces results from trial evaluating XB002
Study involves patients with advanced common cancers and solid tumours
Read More
Author: John Pinching
Cancer diagnoses decrease across England during 2020
Statistics show an average of 789 new malignant cancers diagnosed per day in 2020
Read More
Gedeon Richter announces availability of oral contraception Drovelis
Option contains new, synthetic version of naturally occurring oestrogen
Read More
Apogenix’s asunercept demonstrates efficacy in COVID-19 trial
Therapy showed faster clinical recovery for combined treatment groups
Read More
Grifols’ Tavlesse receives NICE recommendation
Therapy treats refractory chronic immune thrombocytopenia and is available across UK
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
